Cargando…
Alterations in erythrocyte membrane transporter expression levels in type 2 diabetic patients
Type 2 diabetes mellitus (T2DM) is one of the most common multifactorial diseases and several membrane transporters are involved in its development, complications and treatment. We have recently developed a flow-cytometry assay panel for the quantitative determination of red cell membrane protein le...
Autores principales: | Szabó, Edit, Kulin, Anna, Korányi, László, Literáti-Nagy, Botond, Cserepes, Judit, Somogyi, Anikó, Sarkadi, Balázs, Várady, György |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7854743/ https://www.ncbi.nlm.nih.gov/pubmed/33531564 http://dx.doi.org/10.1038/s41598-021-82417-8 |
Ejemplares similares
-
Genetic Modulation of the GLUT1 Transporter Expression—Potential Relevance in Complex Diseases
por: Kulin, Anna, et al.
Publicado: (2022) -
Potential role of the ABCG2-Q141K polymorphism in type 2 diabetes
por: Szabó, Edit, et al.
Publicado: (2021) -
Selective Fluorescent Probes for High-Throughput Functional Diagnostics of the Human Multidrug Transporter P-Glycoprotein (ABCB1)
por: Szabó, Edit, et al.
Publicado: (2022) -
Clinically relevant mutations in the ABCG2 transporter uncovered by genetic analysis linked to erythrocyte membrane protein expression
por: Zámbó, Boglárka, et al.
Publicado: (2018) -
Genetic polymorphisms and decreased protein expression of ABCG2 urate transporters are associated with susceptibility to gout, disease severity and renal-overload hyperuricemia
por: Pálinkás, Márton, et al.
Publicado: (2022)